You are here: Industry Insights > COVID-19

News List

Francis Crick Institute and collaborators to offer COVID-19 testing for key workers europeanpharmaceuticalreview
April 06, 2020
The institute has paused cancer research and repurposed its laboratories and scientists to provide a rapid COVID-19 testing facility for NHS staff and other key workers.
Global confirmed Covid-19 cases exceed one million pharmaceutical-technology
April 06, 2020
Covid-19 cases have crossed one million globally, with the pandemic being responsible for more than 52,000 deaths so far.
Apeiron Biologics gets regulatory approvals for Phase II Covid-19 trial pharmaceutical-technology
April 06, 2020
Apeiron Biologics has secured approvals from regulatory agencies in Austria, Germany and Denmark to conduct a Phase II clinical trial of APN01 for the treatment of Covid-19.
Amgen and Adaptive Biotechnologies to develop Covid-19 drug pharmaceutical-technology
April 06, 2020
Amgen has partnered with Adaptive Biotechnologies to develop a drug candidate that could prevent and treat Covid-19 coronavirus infection.
Covid-19 vaccine candidate yields promising data in mice pharmaceutical-technology
April 06, 2020
Researchers at the University of Pittsburgh School of Medicine in the US have reported encouraging results from initial tests of a Covid-19 vaccine candidate, PittCoVacc, delivered using a fingertip-sized patch in mice.
Novartis and Incyte to trial Jakavi for Covid-19 pharmaceutical-technology
April 06, 2020
Novartis, in alliance with Incyte, has announced plans to evaluate Jakavi (ruxolitinib) in a Phase III clinical trial to treat cytokine storm in patients with severe Covid-19 pneumonia.
FluGen, Bharat Biotech and UW–Madison partner on Covid-19 vaccine pharmaceutical-technology
April 06, 2020
Vaccine development companies FluGen and Bharat Biotech have partnered with the University of Wisconsin–Madison (UWMadison) to develop and evaluate a Covid-19 vaccine candidate, CoroFlu.
Vir Biotechnology and Alnylam expand alliance for Covid-19 drugs pharmaceutical-technology
April 06, 2020
Vir Biotechnology and Alnylam Pharmaceuticals have expanded their multi-target infectious diseases alliance to include up to three targets for SARS-CoV-2, the novel coronavirus that causes Covid-19.
Duke to Expedite Study of COVID-19 Prevention in Healthcare Workers contractpharma
April 06, 2020
The Patient-Centered Outcomes Research Institute has funded up to $50 million to evaluate hydroxychloroquine as a preventive drug for the novel coronavirus.
Pharmaseal Offers No Cost Support for COVID-19 Clinical Trials contractpharma
April 06, 2020
Will offer the Engility clinical trials management system at no cost for COVID-19 coronavirus clinical trials.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 437 438 Next page